Correlation Between Erasca and Kura Oncology
Can any of the company-specific risk be diversified away by investing in both Erasca and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erasca and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erasca Inc and Kura Oncology, you can compare the effects of market volatilities on Erasca and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erasca with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erasca and Kura Oncology.
Diversification Opportunities for Erasca and Kura Oncology
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Erasca and Kura is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Erasca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erasca Inc are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Erasca i.e., Erasca and Kura Oncology go up and down completely randomly.
Pair Corralation between Erasca and Kura Oncology
Given the investment horizon of 90 days Erasca Inc is expected to generate 1.56 times more return on investment than Kura Oncology. However, Erasca is 1.56 times more volatile than Kura Oncology. It trades about -0.04 of its potential returns per unit of risk. Kura Oncology is currently generating about -0.16 per unit of risk. If you would invest 260.00 in Erasca Inc on September 22, 2024 and sell it today you would lose (15.00) from holding Erasca Inc or give up 5.77% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Erasca Inc vs. Kura Oncology
Performance |
Timeline |
Erasca Inc |
Kura Oncology |
Erasca and Kura Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Erasca and Kura Oncology
The main advantage of trading using opposite Erasca and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erasca position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.Erasca vs. Century Therapeutics | Erasca vs. Keros Therapeutics | Erasca vs. Monte Rosa Therapeutics | Erasca vs. Design Therapeutics |
Kura Oncology vs. Protagonist Therapeutics | Kura Oncology vs. Merus BV | Kura Oncology vs. Replimune Group | Kura Oncology vs. Kalvista Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |